Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
For the nine months, sales was USD 817.37 million compared to USD 672 million a year ago. Net income was USD 210.53 million compared to USD 125.45 million a year ago. Basic earnings per share from continuing operations was USD 1.34 compared to USD 0.81 a year ago. Diluted earnings per share from continuing operations was USD 1.28 compared to USD 0.7775 a year ago.